PPCB

Propanc Biopharma, Inc.

There isn't enough reported data to score PPCB yet.

PPCB Fundamentals

MetricStatus
Unavailable
Unavailable
Unavailable
Unavailable

There isn't enough reported data to rate PPCB's fundamentals.

PPCB PE Valuation

PPCB has no meaningful PE right now: it lost money over the past year.

PPCB Forward outlook

There aren't enough analyst estimates for PPCB to show an outlook.

PPCB Risk to reward

ScenarioChangePrice
UpsideUnknown—
DownsideUnknown—

Calculated from the latest close: $1.92 on Nov 12.

There is not enough scenario data to assess PPCB's risk to reward.

PPCB Earnings Per Share

PPCB Quarterly Revenue

Q3 2023: --Q4 2023: --Q1 2024: --Q2 2024: --Q3 2024: --Q4 2024: --Q1 2025: --Q2 2025: --Q3 2025: --Q4 2025: --Q1 2026: --Q2 2026: --
Q3 2023: --Q4 2023: --Q1 2024: --Q2 2024: --Q3 2024: --Q4 2024: --Q1 2025: --Q2 2025: --Q3 2025: --Q4 2025: --Q1 2026: --Q2 2026: --

PPCB Free Cash Flow

Q3 2023: −$333,457Q4 2023: −$238,885Q1 2024: −$102,810Q2 2024: −$259,966Q3 2024: −$235,515Q4 2024: −$6,271Q1 2025: −$136,196Q2 2025: −$27,186Q3 2025: −$2MQ4 2025: −$1MQ1 2026: −$1MQ2 2026: −$2M
Q3 2023: −$333,457Q4 2023: −$238,885Q1 2024: −$102,810Q2 2024: −$259,966Q3 2024: −$235,515Q4 2024: −$6,271Q1 2025: −$136,196Q2 2025: −$27,186Q3 2025: −$2MQ4 2025: −$1MQ1 2026: −$1MQ2 2026: −$2M
QuarterFree cash flowYoY
Q2 2026-$1.6M-$1.6M
Q1 2026-$1.1M-$1M
Q4 2025-$1M-$995.1K
Q3 2025-$1.9M-$1.7M
Q2 2025-$27.2K+$232.8K
Q1 2025-$136.2K-$33.4K
Q4 2024-$6.3K+$232.6K
Q3 2024-$235.5K+$97.9K

PPCB has burned cash in almost every quarter: −$6M over the past year, against −$405,168 the year before.

PPCB Total Shares

Q3 2024: 39Q4 2024: 53Q1 2025: 17,304Q2 2025: 15,873Q3 2025: 49,326Q4 2025: 53,441Q1 2026: 89,710
Q3 2024: 39Q4 2024: 53Q1 2025: 17,304Q2 2025: 15,873Q3 2025: 49,326Q4 2025: 53,441Q1 2026: 89,710
PeriodChange %Net change
Quarterly+68%+36.3K shares
1 year+418%+72.4K shares

PPCB has 89,710 diluted shares, up 418% from a year ago.

PPCB Net Leverage

PPCB's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.

PPCB Weekly Momentum

MetricValueStatus
RSI38.3Neutral
Stochastic0.4Oversold

PPCB's weekly RSI is 38 (neutral) and its Stochastic is 0 (oversold).

PPCB PE vs Healthcare Sector

PPCB has no meaningful PE right now: it lost money over the past year.

PPCB Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$3.5045% below
20 week MA$8.7278% below
50 week MA$39.595% below
100 week MA$734.7100% below
200 week MA$392,980.4100% below

PPCB is in a downtrend: it's below all five of its weekly moving averages, and 100% below its 200-week average.

PPCB Yearly ROI

YearStart priceEnd priceROI
2020$56,200,005.0$179,500.0-100%
2021$179,500.0$12,945.0-93%
2022$12,945.0$250.5-98%
2023$250.5$180,150.0+71816%
2024$180,150.0$3,000.0-98%
2025$3,000.0$146.5-95%
2026 YTD$146.5$1.92-99%

PPCB's yearly returns have swung widely, from +71816% in 2023 to −100% in 2020. It's down 99% so far in 2026.

Give your agent the market.

Get API key